Hints and tips:
Related Special Reports
...Pharma groups and biotechs can be locked into contracts with WuXi for up to five years into the future, said Crowley....
...Other drugmakers could still “win” the race in the rapidly growing obesity market dominated by Novo Nordisk and Eli Lilly, according to the chief executive of biotech company Zealand Pharma....
...A new venture, led by the founder of a biotech group that was sold to Sanofi for up to $1.45bn in 2021, has won £48mn in funding for research into cancer treatments using machine learning and genetically...
...Mentioned in this podcast: US biotech fundraising boom ends 2-year deal drought Is the EU’s Covid recovery fund failing?...
...German pharma group Boehringer Ingelheim has struck an up to $1bn partnership with a UK biotech to develop treatments for chronic liver disease that aim to harness the organ’s capacity to regenerate....
...Specification: Biopsychology Click the link below to read the and then answer the questions: UK biotech group raises £48mn for Alzheimer’s research The article notes that “neurons are the fundamental...
...[MUSIC PLAYING] American biotech companies are rushing to raise funds on US stock markets at the fastest rate since the biotech boom of the pandemic....
...A total of nine biotechs have gone public on US markets this quarter, raising $1.4bn between them....
...Europe needs to learn from US shareholders willing to make big bets on biotech if it wants to create a thriving homegrown industry, according to the chief executive of Argenx, one of the bloc’s largest biotech...
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...“Both biotech and non-biotech IPOs benefit from a lot of the same underlying economic circumstances . . ....
...Chinese biotech companies fell, with WuXi Biologics retreating 21 per cent, WuXi AppTec dropping 18 per cent and Pharmaron down 15 per cent....
...US lawmakers have put the sector under scrutiny in relations with China and are seeking to restrict companies with federal funding from contracting with “foreign adversary” biotech groups of “concern” deemed...
...A new biotech company that aims to harness the immune system to treat a range of skin diseases will launch on Monday with $100mn in seed financing....
...It says it needs improved access to capital, but it claims to be one of the largest biotech fundraisers in recent years....
...These techniques — the “holy grail of biotech” — allow genetic improvements to be made remotely with “the ease of a software update”....
...The investor interest in businesses developing psychedelics comes as the broader biotech sector enjoys a revival....
...But Amyris had also branched out into being an incubator for beauty start-ups including Rose Inc, Costa Brazil and JVN hair care, and it proved too huge a leap from developing molecules to developing brands...
...Biotech stocks carry high risks that products under development will fail. Chinese biotechs now come with an added ingredient: political risk....
...A rally in biotech stocks has raised hopes of a turnaround from the sector’s worst run this century, as drug developers suffered from rising interest rates and a backlash to pandemic-era euphoria....
...The Hang Seng Hong Kong-Listed Biotech index has declined more than 7 per cent this week....
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...Shah called for Suresh Katta and Venkat Peri, both chief executives of other biotechs, to be nominated for the independent board roles....
...I unwittingly contributed to a broad bust in UK biotech stocks in the late 1990s by exposing the inaccuracy of claims made by flagship company British Biotech. Its drugs did not work....
...A once-popular fund, the SPDR S&P Biotech ETF, has lost 14 per cent of its value this year, falling 60 per cent from its highs....
International Edition